1,1'-ETHYLIDENEBIS[L-TRYPTOPHAN], AN IMPURITY IN L-TRYPTOPHAN ASSOCIATED WITH EOSINOPHILIA-MYALGIA-SYNDROME, STIMULATES TYPE-I COLLAGEN GENE-EXPRESSION IN HUMAN FIBROBLASTS IN-VITRO
Jg. Zangrilli et al., 1,1'-ETHYLIDENEBIS[L-TRYPTOPHAN], AN IMPURITY IN L-TRYPTOPHAN ASSOCIATED WITH EOSINOPHILIA-MYALGIA-SYNDROME, STIMULATES TYPE-I COLLAGEN GENE-EXPRESSION IN HUMAN FIBROBLASTS IN-VITRO, Biochemistry and molecular biology international, 37(5), 1995, pp. 925-933
Eosinophilia-myalgia syndrome (EMS), a recently described inflammatory
disorder characterized by myalgia, peripheral eosinophilia, and multi
system inflammation is associated with L-tryptophan consumption. Fibro
sis of various tissues due to excessive accumulation of type I collage
n is a prominent late manifestation of the syndrome. 1,1'-Ethylidenebi
s [L-tryptophan] (EBT), an impurity distinct from L-tryptophan found i
n case-associated lots, has been implicated in the pathogenesis of EMS
. We therefore investigated the effects of EBT on normal human fibrobl
ast function in vitro. Incubation of confluent fibroblasts with EBT, b
ut not its hydrolysis product 1-methyl-tetrahydro-beta-carboline-3-car
boxylic acid, caused a dose-dependent increase in collagen synthesis a
nd in type I collagen mRNA levels independent of its effect on prolife
ration. In contrast, expression mRNA for fibronectin was not affected.
These findings indicate that EBT stimulates type I collagen productio
n by human fibroblasts, and suggest that EBT may be involved in the de
velopment of fibrosis in EMS.